Sahajanand Medical Technologies Limited IPO
SMT · Mainboard · 15–19 Oct 2026
Half market demand (GMP, subscription, institutional bids), half offer-document data (valuation, profit trend, fresh issue vs OFS, debt, promoters, sector). Missing inputs are left out, not guessed. Not an apply/avoid recommendation.
240 archived readings. Marketframe stores its own observations; readings before we began archiving cannot be backfilled.
No archived readings yet. Marketframe stores a reading every 15 minutes while an issue is live.
4.94% unofficial premium
Subscription unavailable
Not published yet
Not in the RHP notes yet
Not in the RHP notes yet
Offer split unavailable
Not in the RHP notes yet
Not in the RHP notes yet
Sector not set yet
This IPO is entirely an offer for sale: existing shareholders are selling, and the company itself receives nothing.
Qualified institutional buyers are mutual funds, banks, insurers and foreign funds, and they read the full prospectus. They usually bid on the last day, so a low QIB number early in the window is normal. A low one at the close is not.
Allotment results are published on this registrar's official portal. Select the IPO, then enter your PAN or application number.
in.mpms.mufg.comWhat is the GMP of Sahajanand Medical Technologies Limited today?
The latest unofficial grey market premium for Sahajanand Medical Technologies Limited is ₹43 (4.94% of the upper price band), sourced from InvestorGain. GMP is unofficial and unregulated.
What is the price band of Sahajanand Medical Technologies Limited?
The price band is ₹327–₹344 per share, as filed with NSE.
When does Sahajanand Medical Technologies Limited open and close?
The issue window is 15–19 Oct 2026. The current status is closed.
How much is Sahajanand Medical Technologies Limited subscribed?
Live subscription figures are published by NSE once bidding opens.
Is Sahajanand Medical Technologies Limited a good IPO to apply for?
Marketframe does not publish apply or avoid calls. The Marketframe score combines market demand (GMP, subscription, institutional bids) with facts from the offer document (valuation against listed peers, profit trend, fresh issue vs OFS, debt, promoter holding and sector record). It is an automated summary of data, not a recommendation or investment advice. Read the RHP and consult a SEBI-registered adviser.
↑Issue schedule verified from NSE
↑Price band published
!GMP is unofficial and not verified by NSE
!Read the RHP risk factors before applying
Schedule, price band and live subscription data are sourced from NSE India. *GMP is sourced from InvestorGain, is unofficial and unregulated. The Marketframe score summarises market demand and offer-document data; it does not predict listing gains or returns. Marketframe does not provide investment advice. Verify every decision using SEBI, NSE, BSE and the relevant offer document.